Year: 2021

Zai-Lab-Limited

Zai Lab Announces Positive Topline Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) as First-Line Monotherapy Maintenance Treatment in Chinese Women with Platinum-Responsive Advanced Ovarian Cancer

•   PRIME study demonstrates that niraparib treatment had a clinically meaningful and statistically significant benefit in improving progression-free survival in the overall...

news_6

LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin

GUANGZHOU, China--(BUSINESS WIRE)--LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific...

Broadscale-Acquisition-Corp-

Voltus, Inc. – The Leading Distributed Energy Resource Software Technology Platform – to Combine with Broadscale Acquisition Corp., Creating the First Public Pure-Play Company in the Industry

Voltus is the leading software technology platform monetizing distributed energy resources (DERs) – including demand response, distributed generation (e.g., solar),...